Concepedia

Author

Rachel E. Piddock

Norfolk and Norwich University Hospitals NHS Foundation TrustORCID

Also Known As

R E Piddock, Rachel E Piddock, Rachel E. Piddock, Rachel Piddock

33

Publications

1.2K

Citations

12

H-Index

21

Concepts

All Affiliations

Norfolk and Norwich University Hospitals NHS Foundation TrustUniversity of East AngliaNorwich Research ParkUniversity of Liverpool
RE

About

Rachel E. Piddock is an author at Norfolk and Norwich University Hospitals NHS Foundation Trust specializing in medicine, cell biology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

117

2

Cell Biology

4

4

117

3

Immunology

2

2

57

4

Molecular Biology

1

1

22

5

Cell Signaling

1

1

31

Rachel E. Piddock

×

10

Publications

1.2K

Citations

10

H-Index

YearCitations

NADPH oxidase-2 derived superoxide drives mitochondrial transfer from bone marrow stromal cells to leukemic blasts

Christopher R. Marlein, Lyubov Zaitseva, Rachel E. Piddock,

Blood

2017

325

Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment

Manar Shafat, Thomas Oellerich, Sebastian Mohr,

Blood

2017

321

CD38-Driven Mitochondrial Trafficking Promotes Bioenergetic Plasticity in Multiple Myeloma

Christopher R. Marlein, Rachel E. Piddock, Jayna J. Mistry,

Cancer Research

2019

246

Acute myeloid leukemia induces protumoral p16INK4a-driven senescence in the bone marrow microenvironment

Amina Abdul‐Aziz, Yu Sun, Charlotte Hellmich,

Blood

2018

100

HIF1α drives chemokine factor pro-tumoral signaling pathways in acute myeloid leukemia

Amina Abdul‐Aziz, Manar Shafat, Yu Sun,

Oncogene

2018

38

Targeting PI3Kδ and PI3Kγ signalling disrupts human AML survival and bone marrow stromal cell mediated protection

Genevra Pillinger, Niamh V. Loughran, Rachel E. Piddock,

Oncotarget

2016

31

PI3Kδ and PI3Kγ isoforms have distinct functions in regulating pro-tumoural signalling in the multiple myeloma microenvironment

Rachel E. Piddock, Niamh V. Loughran, Christopher R. Marlein,

Blood Cancer Journal

2017

29

Activity of Bruton's tyrosine-kinase inhibitor ibrutinib in patients with CD117-positive acute myeloid leukaemia: a mechanistic study using patient-derived blast cells

Stuart A. Rushworth, Genevra Pillinger, Amina Abdul‐Aziz,

The Lancet Haematology

2015

26

PGC-1α driven mitochondrial biogenesis in stromal cells underpins mitochondrial trafficking to leukemic blasts

Christopher R. Marlein, Lyubov Zaitseva, Rachel E. Piddock,

Leukemia

2018

22

Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia

Wei‐Yu Lin, Sarah Fordham, Nicola J. Sunter,

Nature Communications

2021

15

Page 1